<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: RE: Performance enhancement with selegiline</title>
<meta name="Author" content="Rafal Smigrodzki (rafal@smigrodzki.org)">
<meta name="Subject" content="RE: Performance enhancement with selegiline">
<meta name="Date" content="2003-02-19">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>RE: Performance enhancement with selegiline</h1>
<!-- received="Wed Feb 19 09:33:08 2003" -->
<!-- isoreceived="20030219163308" -->
<!-- sent="Wed, 19 Feb 2003 11:38:12 -0500" -->
<!-- isosent="20030219163812" -->
<!-- name="Rafal Smigrodzki" -->
<!-- email="rafal@smigrodzki.org" -->
<!-- subject="RE: Performance enhancement with selegiline" -->
<!-- id="BMEDJIBJGLNDOOANGIDLIECGCKAA.rafal@smigrodzki.org" -->
<!-- charset="US-ASCII" -->
<!-- inreplyto="000001c2d6c5$b37eacc0$7f4a87d8@MyPC" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Rafal Smigrodzki (<a href="mailto:rafal@smigrodzki.org?Subject=RE:%20Performance%20enhancement%20with%20selegiline"><em>rafal@smigrodzki.org</em></a>)<br>
<strong>Date:</strong> Wed Feb 19 2003 - 09:38:12 MST
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3091.html">Ramez Naam: "RE: spreading democracy (was: Bush budget has 0 dollars for Afghanistan)"</a>
<ul>
<li><strong>Previous message:</strong> <a href="3089.html">Terry W. Colvin: "IRAK: FWD (TLCB) Saddam's Presidential Palaces - Satellite imagery and  more"</a>
<li><strong>In reply to:</strong> <a href="2896.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3107.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3107.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3090">[ date ]</a>
<a href="index.html#3090">[ thread ]</a>
<a href="subject.html#3090">[ subject ]</a>
<a href="author.html#3090">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
gts wrote:
<br>
<em>&gt; Rafal wrote:
</em><br>
<em>&gt;&gt;&gt;&gt; ### I explained before but can do it again: selegiline did not slow
</em><br>
<em>&gt;&gt;&gt;&gt; the progression of symptoms, merely symptomatically delayed the
</em><br>
<em>&gt;&gt;&gt;&gt; time to levodopa, as shown by the loss of efficacy during washout.
</em><br>
<em>&gt;&gt;&gt;
</em><br>
<em>&gt;&gt;&gt; I stand by my words. Selegiline delayed the time to which symptoms
</em><br>
<em>&gt;&gt;&gt; become severe enough to require treatment with levodopa. That is
</em><br>
<em>&gt;&gt;&gt; &quot;slowing the progression of Parkinson's disease symptoms&quot; by
</em><br>
<em>&gt;&gt;&gt; anyone's definition, Rafal.
</em><br>
<em>&gt;&gt;
</em><br>
<em>&gt;&gt; ### No it isn't. The symptoms appeared at the same rate, but were
</em><br>
<em>&gt;&gt; delayed.
</em><br>
<em>&gt;
</em><br>
<em>&gt; Uhh, excuse me but a delay in the appearance of parkinson's symptoms
</em><br>
<em>&gt; is the same thing as &quot;slowing the progression of symptoms.&quot;
</em><br>
<p>### You might want to peruse some literature on neurodegenerative disorders
<br>
before making this statement. In the medical community the terms &quot;slowing
<br>
progression of disease&quot;, &quot;slowing the progression of symptoms&quot;, and
<br>
&quot;delaying the symptoms&quot;, have distinct meanings. You can see the newest
<br>
issue of &quot;Neurology&quot;, with the review article on &quot;Slowing Parkinson's
<br>
disease progression: recent dopamine agonist trials&quot;
<br>
Neurology. 2003 Feb 11;60(3):381-9.
<br>
<p>Rafal
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="3091.html">Ramez Naam: "RE: spreading democracy (was: Bush budget has 0 dollars for Afghanistan)"</a>
<li><strong>Previous message:</strong> <a href="3089.html">Terry W. Colvin: "IRAK: FWD (TLCB) Saddam's Presidential Palaces - Satellite imagery and  more"</a>
<li><strong>In reply to:</strong> <a href="2896.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="3107.html">gts: "RE: Performance enhancement with selegiline"</a>
<li><strong>Reply:</strong> <a href="3107.html">gts: "RE: Performance enhancement with selegiline"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#3090">[ date ]</a>
<a href="index.html#3090">[ thread ]</a>
<a href="subject.html#3090">[ subject ]</a>
<a href="author.html#3090">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Feb 19 2003 - 09:35:24 MST
</em></small></p>
</body>
</html>
